as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹739.15
Change
+11.8 (1.62%)
Open
₹734.55
Prev. Close
₹727.35
Day High
₹757.9
Day Low
₹732.0
Volume Analysis
Traded
287,888
Delivered
82,713
Delivery %
28.73%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Promoter holding is rising
Weaknesses (2)
- •Low return on equity (-0.13%)
- •Below-average fundamentals quality score (49/100)
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹779.94 | ₹768.92 | ₹754.04 | ₹743.02 | ₹728.14 | ₹717.12 | ₹702.24 |
| Fibonacci | ₹768.92 | ₹759.03 | ₹752.91 | ₹743.02 | ₹733.13 | ₹727.01 | ₹717.12 |
| Camarilla | ₹746.27 | ₹743.9 | ₹741.52 | ₹743.02 | ₹736.78 | ₹734.4 | ₹732.03 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+31.26%
1 Week
-1.87%
1 Month
+18.51%
3 Months
+28.39%
6 Months
+61.0%
1 Year
+20.13%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
DuPont ROE Breakdown
-0.15%
Net margin -0.14% × asset turnover 0.59x × equity multiplier 1.86x
Company Overview
Sector
Healthcare
Market Cap
₹3,587 Cr
P/E (TTM)
840.0
ROE
-0.13%
Book Value
₹346.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 27 Sep 2026. Not investment advice.
TopFund Analysis
Solara Active Pha Sci Ltd scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 49/100. The strongest factor is Momentum (90/100), while Growth (0/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising; low return on equity (-0.13%); below-average fundamentals quality score (49/100). FII holding has been falling.
TopFund Score — Fundamentals Quality
49/100 — WeakData confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- −Company has low interest coverage ratio.
- −The company has delivered a poor sales growth of -3.27% over past five years.
- −Company has a low return on equity of -12.0% over last 3 years.
- −Promoters have pledged 37.1% of their holding.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Company reminded physical shareholders to submit PAN, KYC, bank details and nomination forms.
Income tax rectification order drops Rs.161.92 crore demand for AY 2019-20 to nil.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 352 | 425 | 212 | 299 | 363 | 347 | 300 | 273 | 319 | 314 | 349 | 387 | 382 |
| Expenses + | 333 | 388 | 374 | 290 | 322 | 286 | 243 | 228 | 262 | 279 | 312 | 330 | 320 |
| Operating Profit | 19 | 38 | -162 | 10 | 42 | 61 | 58 | 45 | 57 | 35 | 37 | 58 | 62 |
| OPM % | 5.0% | 9.0% | -76.0% | 3.3% | 12.0% | 18.0% | 19.0% | 17.0% | 18.0% | 11.0% | 11.0% | 15.0% | 16.0% |
| Other Income + | 2 | -4 | -62 | -120 | 1 | 0 | 1 | 6 | 1 | 0 | -7 | 6 | 3 |
| Interest | 25 | 24 | 25 | 31 | 31 | 28 | 27 | 29 | 24 | 21 | 22 | 28 | 22 |
| Depreciation | 26 | 26 | 26 | 25 | 25 | 25 | 25 | 24 | 24 | 24 | 26 | 26 | 27 |
| Profit before tax | -29 | -17 | -275 | -167 | -13 | 8 | 8 | -2 | 11 | -10 | -17 | 10 | 16 |
| Tax % | -35.0% | 0.0% | 0.0% | 53.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit + | -19 | -17 | -275 | -255 | -13 | 8 | 8 | -2 | 11 | -10 | -17 | 10 | 16 |
| EPS in Rs | -4 | -4 | -57 | -53 | -4 | 2 | 2 | -1 | 3 | -3 | -5 | 3 | 3 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 521 | 1,387 | 1,322 | 1,617 | 1,268 | 1,444 | 1,289 | 1,284 | 1,369 | 1,431 |
| Expenses + | 464 | 1,174 | 1,062 | 1,231 | 1,188 | 1,309 | 1,384 | 1,077 | 1,182 | 1,240 |
| Operating Profit | 57 | 213 | 260 | 386 | 81 | 134 | -95 | 206 | 187 | 192 |
| OPM % | 11.0% | 15.0% | 20.0% | 24.0% | 6.0% | 9.0% | -7.0% | 16.0% | 14.0% | 13.0% |
| Other Income + | 2 | 12 | 27 | 29 | 16 | 22 | -185 | 8 | 0 | 2 |
| Interest | 25 | 82 | 78 | 84 | 75 | 90 | 105 | 115 | 95 | 92 |
| Depreciation | 34 | 83 | 94 | 109 | 112 | 111 | 103 | 99 | 100 | 103 |
| Profit before tax | 0 | 60 | 115 | 222 | -91 | -45 | -488 | 1 | -7 | -2 |
| Tax % | -70.0% | 1.0% | 0.0% | 0.0% | -36.0% | -50.0% | 16.0% | 0.0% | 0.0% | — |
| Net Profit + | 0 | 59 | 115 | 221 | -58 | -22 | -567 | 1 | -7 | -2 |
| EPS in Rs | — | 17 | 32 | 46 | -12 | -5 | -118 | 0 | -2 | -2 |
| Dividend Payout % | 0.0% | 22.0% | 5.0% | 11.0% | 0.0% | -49.0% | 0.0% | 0.0% | 0.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Reserves | 739 | 930 | 1,059 | 1,553 | 1,489 | 1,464 | 898 | 1,054 | 1,208 |
| Borrowings + | 633 | 538 | 722 | 621 | 1,037 | 1,013 | 1,012 | 796 | 687 |
| Other Liabilities + | 425 | 466 | 346 | 404 | 383 | 386 | 406 | 342 | 393 |
| Total Liabilities | 1,821 | 1,960 | 2,153 | 2,614 | 2,945 | 2,899 | 2,351 | 2,232 | 2,333 |
| Fixed Assets + | 1,086 | 1,218 | 1,397 | 1,382 | 1,356 | 1,364 | 1,268 | 1,193 | 1,238 |
| CWIP | 71 | 40 | 40 | 88 | 239 | 238 | 256 | 280 | 205 |
| Investments | 1 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 5 |
| Other Assets + | 663 | 701 | 716 | 1,144 | 1,350 | 1,295 | 825 | 757 | 886 |
| Total Assets | 1,821 | 1,960 | 2,153 | 2,614 | 2,945 | 2,899 | 2,351 | 2,232 | 2,333 |
| Equity Capital | 25 | 26 | 27 | 36 | 36 | 36 | 36 | 40 | 45 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 49 | 166 | 242 | 155 | -242 | 156 | 109 | 213 | 153 |
| Cash from Investing Activity + | -85 | -113 | -359 | -106 | -243 | -81 | -4 | -37 | -99 |
| Cash from Financing Activity + | 68 | -23 | 97 | 92 | 334 | -113 | -106 | -180 | -54 |
| Net Cash Flow | 31 | 30 | -20 | 142 | -151 | -38 | 0 | -4 | 1 |
| CFO/OP | 92 | 85 | 103 | 49 | -277 | 106 | -113 | 104 | 83 |
| Free Cash Flow | 14 | 108 | -25 | -16 | -451 | 46 | 69 | 173 | 101 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 43.16% | 51.14% | 50.73% | 45.89% | 45.11% | 44.92% | 44.82% | 41.1% | 41.71% | 42.37% | 42.66% | 42.79% |
| Promoters | 37.19% | 30.49% | 30.49% | 37.27% | 37.27% | 37.23% | 37.94% | 42.01% | 42.01% | 42.0% | 42.0% | 41.93% |
| FII | 17.86% | 16.62% | 15.8% | 14.0% | 14.25% | 14.67% | 14.63% | 14.25% | 13.58% | 11.98% | 11.59% | 11.52% |
| DII | 1.79% | 1.75% | 2.97% | 2.83% | 3.37% | 3.19% | 2.61% | 2.62% | 2.69% | 3.64% | 3.75% | 3.74% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Solara Active Pha Sci Ltd (this stock) | 3,587 | 840.0 | 2.14 | -0.13% |
| Ind Swift Laboratories Lt | 3,489 | 53.6 | 2.52 | 3.87% |
| Kwality Pharmaceuticals L | 3,824 | 46.8 | 11.48 | 22.6% |
| Unichem Laboratories Ltd | 3,870 | 31.7 | 1.42 | 3.17% |
| Advanced Enzyme Tech Ltd | 3,278 | 20.8 | 2.01 | 10.2% |
| Aarti Drugs Ltd. | 3,991 | 20.7 | 2.57 | 13.4% |
| Gufic Biosciences Ltd. | 4,237 | 57.7 | 6.37 | 10.1% |
Which Mutual Funds Hold Solara Active Pha Sci Ltd?
Frequently Asked Questions about Solara Active Pha Sci Ltd
Solara Active Pha Sci Ltd (SOLARA) closed at ₹739.15 on NSE on 25 September 2026, up 11.8 (1.62%) from the previous close.
Solara Active Pha Sci Ltd trades on the NSE (National Stock Exchange of India) under the symbol SOLARA.
Solara Active Pha Sci Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 840.0.
Solara Active Pha Sci Ltd has a dividend yield of 0.0%.
Solara Active Pha Sci Ltd's 52-week high is ₹774.0 and its 52-week low is ₹422.0.
Solara Active Pha Sci Ltd has a market capitalisation of ₹3,587 crore.
Solara Active Pha Sci Ltd has a TopFund Quality Score of 49/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Solara Active Pha Sci Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.